These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 2435442)

  • 1. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retention time of colloid-osmotic infusions].
    Halmágyi M
    Beitr Infusionther Klin Ernahr; 1979; 2():51-68. PubMed ID: 94261
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma volume changes after infusion of various plasma expanders.
    Lamke LO; Liljedahl SO
    Resuscitation; 1976; 5(2):93-102. PubMed ID: 69313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Storing of plasma expanders in the reticuloendothelial system].
    Sonntag W; Paulini K
    Verh Dtsch Ges Pathol; 1978; 62():346. PubMed ID: 85388
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyethyl starch.
    Thompson WL
    Dev Biol Stand; 1980; 48():259-66. PubMed ID: 6168505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of low molecular (monovalent) dextran (Dx 1) in volunteers.
    Schwarz JA; Koch W; Bühler V; Kaumeier S
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):358-67. PubMed ID: 6171533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.
    Kroemer H; Haass A; Müller K; Jäger H; Wagner EM; Heimburg P; Klotz U
    Eur J Clin Pharmacol; 1987; 31(6):705-10. PubMed ID: 2435558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the plasma volume-expanding effects of 6% dextran 70, 5% albumin, and 6% HES 130/0.4 after hemorrhage in the guinea pig.
    Dubniks M; Persson J; Grände PO
    J Trauma; 2009 Dec; 67(6):1200-4. PubMed ID: 20009667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the liberation of urinary necrosis enzymes (NAG-AAP) after administration of plasma expanders: study of dextran 40, hydroxyethyl starch and polymerized gelatin].
    Lanza V; Guglielmo L; Sapio M; Sanfilippo A; La Chiusa S
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1155-61. PubMed ID: 2483317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of plasma substitutes of different molecular weight in acute haemorrhagic shock in dogs (author's transl)].
    Klose R; Hartung HJ; Ruffmann R; Lutz H
    Prakt Anaesth; 1979 Aug; 14(4):337-44. PubMed ID: 91161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of colloidal solutions in dengue hemorrhagic fever patients.
    Kalayanarooj S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S97-103. PubMed ID: 19253503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the plasma half-life of trichosanthin by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Yung MH; Shaw PC; Tam SC
    Biochem Pharmacol; 1991 Oct; 42(9):1721-8. PubMed ID: 1718284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo effects of plasma substitutes on the rheologic properties of blood].
    Donner M; De Wachter P; Cauchois G; Gentils M; Kurtz M; Laxenaire MC; Stoltz JF
    J Mal Vasc; 1993; 18(2):126-33. PubMed ID: 7688783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrafiltration and absorption characteristics of hydroxyethylstarch and dextran during long dwell peritoneal dialysis exchanges in rats.
    Hain H; Schütte W; Pustelnik A; Gahl G; Kessel M
    Adv Perit Dial; 1989; 5():28-30. PubMed ID: 2484983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation, hemostasis, and plasma expanders:a quarter century enigma.
    Alexander B; Odake K; Lawlor D; Swanger M
    Fed Proc; 1975 May; 34(6):1429-40. PubMed ID: 47813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.